RGNX
Price
$9.35
Change
-$0.00 (-0.00%)
Updated
Oct 3 closing price
33 days until earnings call
VRPX
Price
$0.65
Change
-$0.00 (-0.00%)
Updated
Oct 3 closing price
Ad is loading...

RGNX vs VRPX

Header iconRGNX vs VRPX Comparison
Open Charts RGNX vs VRPXBanner chart's image
REGENXBIO
Price$9.35
Change-$0.00 (-0.00%)
Volume$643.96K
CapitalizationN/A
Virpax Pharmaceuticals
Price$0.65
Change-$0.00 (-0.00%)
Volume$44.47K
CapitalizationN/A
View a ticker or compare two or three
RGNX vs VRPX Comparison Chart
Loading...
RGNX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VRPX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
RGNX vs. VRPX commentary
Oct 04, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGNX is a StrongBuy and VRPX is a Sell.

COMPARISON
Comparison
Oct 04, 2024
Stock price -- (RGNX: $9.35 vs. VRPX: $0.65)
Brand notoriety: RGNX and VRPX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RGNX: 127% vs. VRPX: 17%
Market capitalization -- RGNX: $518.45M vs. VRPX: $3.31M
RGNX [@Biotechnology] is valued at $518.45M. VRPX’s [@Biotechnology] market capitalization is $3.31M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RGNX’s FA Score shows that 0 FA rating(s) are green whileVRPX’s FA Score has 1 green FA rating(s).

  • RGNX’s FA Score: 0 green, 5 red.
  • VRPX’s FA Score: 1 green, 4 red.
According to our system of comparison, VRPX is a better buy in the long-term than RGNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RGNX’s TA Score shows that 3 TA indicator(s) are bullish while VRPX’s TA Score has 3 bullish TA indicator(s).

  • RGNX’s TA Score: 3 bullish, 6 bearish.
  • VRPX’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, VRPX is a better buy in the short-term than RGNX.

Price Growth

RGNX (@Biotechnology) experienced а -12.45% price change this week, while VRPX (@Biotechnology) price change was -4.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.51%. For the same industry, the average monthly price growth was +3.11%, and the average quarterly price growth was -5.53%.

Reported Earning Dates

RGNX is expected to report earnings on Nov 06, 2024.

VRPX is expected to report earnings on May 14, 2024.

Industries' Descriptions

@Biotechnology (+3.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RGNX($518M) has a higher market cap than VRPX($3.31M). RGNX YTD gains are higher at: -47.911 vs. VRPX (-79.635). VRPX has higher annual earnings (EBITDA): -18.97M vs. RGNX (-218.88M). RGNX has more cash in the bank: 290M vs. VRPX (1.87M). VRPX has less debt than RGNX: VRPX (1.07M) vs RGNX (85.5M). RGNX has higher revenues than VRPX: RGNX (89M) vs VRPX (0).
RGNXVRPXRGNX / VRPX
Capitalization518M3.31M15,631%
EBITDA-218.88M-18.97M1,154%
Gain YTD-47.911-79.63560%
P/E RatioN/AN/A-
Revenue89M0-
Total Cash290M1.87M15,500%
Total Debt85.5M1.07M7,976%
FUNDAMENTALS RATINGS
RGNX: Fundamental Ratings
RGNX
OUTLOOK RATING
1..100
51
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
87
P/E GROWTH RATING
1..100
36
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RGNXVRPX
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 24 days ago
75%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
RGNX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VRPX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PDEZX17.93N/A
N/A
PGIM Jennison Emerging Markets Eq Opps Z
JHEIX21.07N/A
N/A
JHancock Equity Income A
INRSX17.75-0.05
-0.28%
Delaware Ivy Natural Resources R6
FCPGX33.07-0.14
-0.42%
Fidelity Small Cap Growth
FCGPX21.01-0.10
-0.47%
NYLI PineStone Global Equity Class P

RGNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RGNX has been loosely correlated with AXON. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if RGNX jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGNX
1D Price
Change %
RGNX100%
-5.75%
AXON - RGNX
48%
Loosely correlated
+2.61%
BEAM - RGNX
46%
Loosely correlated
-2.38%
CRSP - RGNX
46%
Loosely correlated
-1.77%
PRTA - RGNX
45%
Loosely correlated
+0.72%
DNLI - RGNX
44%
Loosely correlated
-2.79%
More

VRPX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRPX has been loosely correlated with BOLT. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if VRPX jumps, then BOLT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRPX
1D Price
Change %
VRPX100%
-3.75%
BOLT - VRPX
44%
Loosely correlated
-0.96%
SCPX - VRPX
37%
Loosely correlated
-3.31%
CRDF - VRPX
34%
Loosely correlated
-1.94%
RGNX - VRPX
33%
Loosely correlated
-5.75%
ACET - VRPX
32%
Poorly correlated
-4.70%
More